Valuing A Cure


In January 2019, ICER launched a year-long project to engage with experts, US stakeholders, and influential international agencies to develop, test, and build consensus around methodological options for determining value-based prices for potential cures. ICER will ultimately create a roadmap for value assessment of potential cures that will have a direct and significant impact on coverage and pricing recommendations for the coming generation of innovative new treatments.

Key Dates

Associated Materials


01/23/2019 – 02/20/2019
Open Input Period

White Paper

06/28/2019 – 07/26/2019
Public Comments

White Paper